Meri Utriainen

Meri Utriainen

Auto-generated profile, based on publicly available information

Meri Utriainen

Comprehensive Cancer Center Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2002 in Cancer
Verified
Journal Article
Open access
PDF file
MUMeri Utriainen
Meri Utriainen
LMLiisa Metsähonkala
Liisa Metsähonkala
TSToivo T. Salmi
Toivo T. Salmi
TUTapio Utriainen
Tapio Utriainen
HKHannu Kalimo
Hannu Kalimo
HMHeikki Minn
Heikki Minn
BACKGROUND: Positron emission tomography (PET) scans of primary brain tumors were performed in pediatric patients to examine whether metabolic characteristics could be used as an index of clinical aggressiveness.METHODS: Twenty‐seven pediatric patients with untreated primary central nervous system neoplasms were studied with PET scans using 2‐[18F] fluoro‐2‐deoxy‐D‐glucose (FDG) and/or L‐[methyl‐11C] methionine (MET). Metabolic characteristics as assessed with FDG and MET standardized uptake values (SUV) and SUV‐to‐normal brain ratios were compared with histopathology and selected histochemical features such as proliferation activity (Ki‐67MIB‐1) and apoptotic, vascular, and cell density indices. The median followup time was 43 months.RESULTS: The accumulation of both FDG and MET was significantly higher in high‐grade than in low‐grade tumors, but a considerable overlap was found. The accumulation of both tracers was associated positively with age. High‐grade tumors showed higher proliferative activity and vascularity than the low‐grade tumors. In univariate analysis, FDG‐PET, MET‐PET, and apoptotic index were independent predictors of event‐free survival.CONCLUSION: We found that both FDG and MET uptake in pediatric brain tumors are associated with malignancy grade. However, no clear limits of SUVs and SUV‐to‐normal brain ratios can be set between low‐grade and high‐grade tumors, which makes the assessment of malignancy grade using metabolic imaging with PET scan difficult in individual cases. Although FDG‐PET and MET‐PET do not compensate for histopathologic evaluation, they may give valuable additional information especially if invasive procedures to obtain histopathologic samples are not feasible. Cancer 2002;95:1376–86. © 2002 American Cancer Society.DOI 10.1002/cncr.10798

1 May 2003 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
MUM. Utriainen
M. Utriainen
MKM. Komu
M. Komu
VVV. Vuorinen
V. Vuorinen
PLP. Lehikoinen
P. Lehikoinen
PSP. Sonninen
P. Sonninen
HMH. Minn
H. Minn

1 September 2012
Verified
Journal Article
Closed access
TSTiina Saarto
Tiina Saarto
HPHeidi Marika Penttinen
Heidi Marika Penttinen
HSHarri Sievänen
Harri Sievänen
PKPirkko-Liisa Kellokumpu-Lehtinen
Pirkko-Liisa Kellokumpu-Lehtinen
LHLiisa Hakamies-Blomqvist
Liisa Hakamies-Blomqvist
MLMinna-Liisa Luoma
Minna-Liisa Luoma

1 April 2013
Verified
Journal Article
Closed access
AEAnneli Elme
Anneli Elme
MUMeri Utriainen
Meri Utriainen
PKPirkko Kellokumpu-Lehtinen
Pirkko Kellokumpu-Lehtinen
TPTiina Palva
Tiina Palva
RLRiitta Luoto
Riitta Luoto
TSTiina Saarto
Tiina Saarto

12 October 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
GPGreta Pettini
Greta Pettini
Sanchini VirginiaSanchini Virginia
Sanchini Virginia
RPRuth Pat-Horenczyk
Ruth Pat-Horenczyk
BSBerta Sousa
Berta Sousa
MMMarianna Masiero
Marianna Masiero
KMKetti Mazzocco
Ketti Mazzocco
Background: Despite the continued progress of medicine, dealing with breast cancer is becoming a major socioeconomic challenge, particularly due to its increasing incidence. The ability to better manage and adapt to the entire care process depends not only on the type of cancer but also on the patient’s sociodemographic and psychological characteristics as well as on the social environment in which a person lives and interacts. Therefore, it is important to understand which factors may contribute to successful adaptation to breast cancer. To our knowledge, no studies have been performed on the combination effect of multiple psychological, biological, and functional variables in predicting the patient’s ability to bounce back from a stressful life event, such as a breast cancer diagnosis. Here we describe the study protocol of a multicenter clinical study entitled “Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back” or, in short, BOUNCE. Objective: The aim of the study is to build a quantitative mathematical model of factors associated with the capacity for optimal adjustment to cancer and to study resilience through the cancer continuum in a population of patients with breast cancer. Methods: A total of 660 women with breast cancer will be recruited from five European cancer centers in Italy, Finland, Israel, and Portugal. Biomedical and psychosocial variables will be collected using the Noona Healthcare platform. Psychosocial, sociodemographic, lifestyle, and clinical variables will be measured every 3 months, starting from presurgery assessment (ie, baseline) to 18 months after surgery. Temporal data mining, time-series prediction, sequence classification methods, clustering time-series data, and temporal association rules will be used to develop the predictive model. Results: The recruitment process stared in January 2019 and ended in November 2021. Preliminary results have been published in a scientific journal and are available for consultation on the BOUNCE project website. Data analysis and dissemination of the study results will be performed in 2022. Conclusions: This study will develop a predictive model that is able to describe individual resilience and identify different resilience trajectories along the care process. The results will allow the implementation of tailored interventions according to patients’ needs, supported by eHealth technologies. Trial Registration: ClinicalTrials.gov NCT05095675; https://clinicaltrials.gov/ct2/show/NCT05095675 International Registered Report Identifier (IRRID): DERR1-10.2196/34564

1 January 2024 in The Breast Journal
Verified
Journal Article
Open access
PPPaula Poikonen-Saksela
Paula Poikonen-Saksela
EKEvangelos Karademas
Evangelos Karademas
LVLeena Vehmanen
Leena Vehmanen
MUMeri Utriainen
Meri Utriainen
Haridimos KondylakisHaridimos Kondylakis
Haridimos Kondylakis
JMJohanna Mattson
Johanna Mattson
Background. Despite excellent prognosis of early breast cancer, the patients face problems related to decreased quality of life and mental health. There is a need for easily available interventions targeting modifiable factors related to these problems. The aim of this study was to test the use of a new digital supportive intervention platform for early breast cancer patients. Material and Methods. Ninety‐seven early breast cancer patients answered questions on wellbeing, exercise, and sociodemographic factors before systemic adjuvant treatment at the Helsinki University Hospital. Based on these answers and predictive algorithms for anxiety and depression, they were guided onto one or several digital intervention paths. Patients under 56 years of age were guided onto a nutrition path, those who exercised less than the current guideline recommendations onto an exercise path, and those at risk of mental health deterioration onto an empowerment path. Information on compliance was collected at 3 months on the amount of exercise and quality of life using EORTC‐C30 scale, anxiety and depression using HADS scale at baseline and 12 months, and log‐in information at 3 and 12 months. Results. Thirty‐two patients followed the empowerment path, 43 the nutrition path, and 75 the exercise path. On a scale of 1–5, most of the participants (mean = 3.4; SD 0.815) found the interventions helpful and would have recommended testing and supportive interventions to their peers (mean = 3.70; SD 0.961). During the 10‐week intervention period, the mean number of log‐ins to the empowerment path was 3.69 (SD = 4.24); the nutrition path, 4.32 (SD = 2.891); and the exercise path, 8.33 (SD = 6.293). The higher number of log‐ins to the empowerment (rho = 0.531, P = 0.008, and n = 24) and exercise paths (rho = 0.330, P = 0.01, and n = 59) was related to better global quality of life at one year. The number of log‐ins correlated to the weekly amount of exercise in the exercise path (cc 0.740, P value <0.001, and n = 20). Conclusion. Patients’ attitudes towards the interventions were positive, but they used them far less than was recommended. A randomized trial would be needed to test the effect of interventions on patients’ QoL and mental health.